
Quest Diagnostics posts strong Q2 results, raises full-year revenue forecast with Barclays lifting price target.
Quest Diagnostics reported a 10.2% revenue increase to $3.04 billion in Q2 2026, driven by a 10% rise in organic revenue and a 13.1% volume increase. Adjusted EPS rose to $3.12, beating analyst expectations of $2.83. Due to strong demand and successf...

